Literature DB >> 25290786

Impact of angiosome-oriented revascularization on clinical outcomes in critical limb ischemia patients without concurrent wound infection and diabetes.

Osamu Iida1, Mitsuyoshi Takahara, Yoshimitsu Soga, Yasutaka Yamauchi, Keisuke Hirano, Junichi Tazaki, Terutoshi Yamaoka, Nobuhiro Suematsu, Kenji Suzuki, Yoshiaki Shintani, Yusuke Miyashita, Masaaki Uematsu.   

Abstract

PURPOSE: To investigate the impact of angiosome-oriented revascularization on clinical outcomes in critical limb ischemia (CLI) patients excluding those with both diabetes and wound infection.
METHODS: Using a retrospective multicenter database, a propensity score matching analysis was performed of 539 consecutive CLI patients (375 men; mean age 71±11 years) without concurrent wound infection and diabetes who underwent balloon angioplasty of isolated infrapopliteal lesions. Propensity score matching produced 2 groups of 182 patients each who underwent angiosome-oriented direct revascularization (123 men; mean age 72±11 years) or indirect revascularization (125 men; mean age 72±11 years). The groups were compared for wound healing rate, freedom from major adverse limb events (MALE), and amputation-free survival (AFS).
RESULTS: In the overall population, indirect revascularization was performed in 36.6% (n=197). In the propensity matching analysis, the complete wound healing rate at 12 months was higher in the direct group than the indirect revascularization patients (75% vs. 64%, p=0.01), while freedom from MALE (p=0.99) and AFS (p=0.17) were not significantly different at up to 24 months. In multivariate analysis, indirect revascularization had an independent negative impact on wound healing (adjusted hazard ratio 0.7, p=0.008).
CONCLUSION: After propensity matching analysis for CLI patients other than those with both diabetes and wound infection, the wound healing rate was higher after direct revascularization than after indirect revascularization, whereas MALE and AFS were not significantly different.

Entities:  

Keywords:  amputation; angiosome; balloon angioplasty; critical limb ischemia; diabetes; endovascular therapy; infection; infrapopliteal arteries; propensity matching analysis; reintervention; revascularization; ulcer; wound healing

Mesh:

Year:  2014        PMID: 25290786     DOI: 10.1583/14-4692R.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  9 in total

Review 1.  Endovascular Treatment of Infrapopliteal Peripheral Artery Disease.

Authors:  Ehrin J Armstrong; Kalkidan Bishu; Stephen W Waldo
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

2.  Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee.

Authors:  Maria Teresa B Abola; Jonathan Golledge; Tetsuro Miyata; Seung-Woon Rha; Bryan P Yan; Timothy C Dy; Marie Simonette V Ganzon; Pankaj Kumar Handa; Salim Harris; Jiang Zhisheng; Ramakrishna Pinjala; Peter Ashley Robless; Hiroyoshi Yokoi; Elaine B Alajar; April Ann Bermudez-Delos Santos; Elmer Jasper B Llanes; Gay Marjorie Obrado-Nabablit; Noemi S Pestaño; Felix Eduardo Punzalan; Bernadette Tumanan-Mendoza
Journal:  J Atheroscler Thromb       Date:  2020-07-04       Impact factor: 4.928

3.  Clinical results of single-vessel versus multiple-vessel infrapopliteal intervention.

Authors:  Jeremy D Darling; John C McCallum; Peter A Soden; John J Hon; Raul J Guzman; Mark C Wyers; Hence J Verhagen; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-08-31       Impact factor: 4.268

4.  Impaired pedal arch affects the treatment effect in patients with single tibial artery revascularization demonstrated by intraoperative perfusion.

Authors:  Jiang Shao; Jiangyu Ma; Zhichao Lai; Xiaoxi Yu; Kang Li; Leyin Xu; Junye Chen; Chaonan Wang; Wenteng Cao; Xiaolong Liu; Jinghui Yuan; Bao Liu
Journal:  Quant Imaging Med Surg       Date:  2022-06

5.  The Role of Interventional Radiology in the Treatment of Arterial Diabetic Foot Disease.

Authors:  Jim A Reekers
Journal:  Cardiovasc Intervent Radiol       Date:  2016-07-19       Impact factor: 2.740

6.  Angiosome~From the Standpoint of Bypass Surgery.

Authors:  Juno Deguchi
Journal:  Ann Vasc Dis       Date:  2020-06-25

7.  Is Angiosome-Guided Endovascular Therapy Worthwhile?

Authors:  Yosuke Hata; Osamu Iida; Toshiaki Mano
Journal:  Ann Vasc Dis       Date:  2019-09-25

Review 8.  Strategies to Overcome the Barrier of Ischemic Microenvironment in Cell Therapy of Cardiovascular Disease.

Authors:  Rouven Berndt; Martin Albrecht; René Rusch
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

9.  Radiotracer Imaging Allows for Noninvasive Detection and Quantification of Abnormalities in Angiosome Foot Perfusion in Diabetic Patients With Critical Limb Ischemia and Nonhealing Wounds.

Authors:  Jessica L Alvelo; Xenophon Papademetris; Carlos Mena-Hurtado; Sangchoon Jeon; Bauer E Sumpio; Albert J Sinusas; Mitchel R Stacy
Journal:  Circ Cardiovasc Imaging       Date:  2018-05       Impact factor: 7.792

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.